Back

Results - Announcements

Sales rise 10.51% to Rs 2246.69 crore

Ipca Laboratories consolidated net profit rises 13.81% in the March 2025 quarter

29-May-2025, 03:47
Net profit of Ipca Laboratories rose 13.81% to Rs 67.82 crore in the quarter ended March 2025 as against Rs 59.59 crore during the previous quarter ended March 2024. Sales rose 10.51% to Rs 2246.69 crore in the quarter ended March 2025 as against Rs 2033.03 crore during the previous quarter ended March 2024.

For the full year,net profit rose 34.77% to Rs 737.68 crore in the year ended March 2025 as against Rs 547.35 crore during the previous year ended March 2024. Sales rose 16.02% to Rs 8939.59 crore in the year ended March 2025 as against Rs 7705.04 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	2246.69	2033.03	11	8939.59	7705.04	16
OPM %	19.09	15.83	-	19.31	17.15	-
PBDT	433.17	311.45	39	1734.01	1307.66	33
PBT	333.05	213.32	56	1336.19	950.42	41
NP	67.82	59.59	14	737.68	547.35	35